Monday, March 1, 2021

DTx Pharma Finds $100M

San Diego-based DTx Pharma, a biotech startup which is developing RNA-based therapeutics to treat diseases, says it has raised $100M in its Series B funding round. The funding was led by RA Capital Management and also included new investors Access Biotechnology, Surveyor Capital (a Citadel company), Cormorant Asset Management, Janus Henderson Investors

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.